Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 9Breast Neoplasms 8Lymphoma, Mantle-Cell 7Leukemia, Myeloid, Acute 7Leukemia 7Congenital Abnormalities 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Myeloproliferative Disorders 6Multiple Myeloma 6Lymphoma, Follicular 6Lymphoma, B-Cell, Marginal Zone 6Lymphoma, Non-Hodgkin 5Lymphoma, Large B-Cell, Diffuse 5Burkitt Lymphoma 5Waldenstrom Macroglobulinemia 4Myelodysplastic Syndromes 4Lymphoma, Large-Cell, Immunoblastic 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Myeloid, Chronic-Phase 4Colorectal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Sezary Syndrome 3Mycosis Fungoides 3Melanoma 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, Extranodal NK-T-Cell 3Lymphoma 3Lung Neoplasms 3Leukemia, Myeloid, Accelerated Phase 3Hodgkin Disease 3

Interventions

Ipilimumab 17Nivolumab 15incomplete Freund's adjuvant 8Cyclophosphamide 7CTLA-4 Antigen 7pembrolizumab 6Ranibizumab 6sargramostim 5Radiosurgery 5Blood Specimen Collection 5tebentafusp 4Temozolomide 4Surveys and Questionnaires 4Magnetic Resonance Spectroscopy 4MART-1 Antigen 4Granulocyte-Macrophage Colony-Stimulating Factor 4Biopsy 4Bevacizumab 4fludarabine phosphate 3fludarabine 3aflibercept 3Thalidomide 3Sunitinib 3Specimen Handling 3MAGEA3 protein, human 3Interleukin-2 3130-nm albumin-bound paclitaxel 3relatlimab 2olaparib 2montanide ISA 51 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Uveal Melanoma × In Situ Hybridization, Fluorescence × Clear all
NCT00952939 2015-01-30

Study of Tumor Samples in Patients Undergoing Radiation Therapy or Surgery For Primary Melanoma of the Eye

Case Comprehensive Cancer Center

Completed
150 enrolled
Dermatologic

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡